BG104705A - Заместен 1,2,4-триазоло/3,4-а/пиридазин - Google Patents

Заместен 1,2,4-триазоло/3,4-а/пиридазин Download PDF

Info

Publication number
BG104705A
BG104705A BG104705A BG10470500A BG104705A BG 104705 A BG104705 A BG 104705A BG 104705 A BG104705 A BG 104705A BG 10470500 A BG10470500 A BG 10470500A BG 104705 A BG104705 A BG 104705A
Authority
BG
Bulgaria
Prior art keywords
compound
triazolo
phthalazine
methylisoxazol
methyloxy
Prior art date
Application number
BG104705A
Other languages
Bulgarian (bg)
English (en)
Inventor
William Carling
Tamara Ladduwahetty
Angus Macleod
Kelvin MERCHANT
Kevin Moore
Francine Sternfeld
Leslie STREET
Original Assignee
Merck Sharp & Dohme Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9803992.8A external-priority patent/GB9803992D0/en
Priority claimed from PCT/GB1998/001307 external-priority patent/WO1998050385A1/en
Priority claimed from GBGB9824896.6A external-priority patent/GB9824896D0/en
Application filed by Merck Sharp & Dohme Limited filed Critical Merck Sharp & Dohme Limited
Publication of BG104705A publication Critical patent/BG104705A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG104705A 1998-02-25 2000-08-22 Заместен 1,2,4-триазоло/3,4-а/пиридазин BG104705A (bg)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9803992.8A GB9803992D0 (en) 1998-02-25 1998-02-25 Therapeutic agents
PCT/GB1998/001307 WO1998050385A1 (en) 1997-05-08 1998-05-06 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
GBGB9824896.6A GB9824896D0 (en) 1998-11-12 1998-11-12 Therapeutic compound
PCT/GB1999/000485 WO1999043677A1 (en) 1998-02-25 1999-02-17 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PYRIDAZINE

Publications (1)

Publication Number Publication Date
BG104705A true BG104705A (bg) 2001-04-30

Family

ID=27269184

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104705A BG104705A (bg) 1998-02-25 2000-08-22 Заместен 1,2,4-триазоло/3,4-а/пиридазин

Country Status (14)

Country Link
EP (1) EP1070066A1 (ru)
JP (1) JP2002504554A (ru)
CN (1) CN1291194A (ru)
AU (1) AU746719B2 (ru)
BG (1) BG104705A (ru)
CA (1) CA2317416A1 (ru)
EA (1) EA002824B1 (ru)
HR (1) HRP20000555A2 (ru)
HU (1) HUP0100647A3 (ru)
NZ (1) NZ505695A (ru)
PL (1) PL341975A1 (ru)
SK (1) SK12772000A3 (ru)
TR (1) TR200002469T2 (ru)
WO (1) WO1999043677A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH21834A (en) * 1982-01-18 1988-03-17 Lepetit Spa New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
WO1998004560A1 (en) * 1996-07-25 1998-02-05 Merck Sharp & Dohme Limited SUBSTITUTED TRIAZOLO PYRIDAZINE DERIVATIVES AS INVERSE AGONISTS OF THE GABAAα5 RECEPTOR SUBTYPE
CA2288789C (en) * 1997-05-08 2009-07-21 Merck Sharp & Dohme Limited Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands

Also Published As

Publication number Publication date
WO1999043677A1 (en) 1999-09-02
CA2317416A1 (en) 1999-09-02
HUP0100647A3 (en) 2003-03-28
CN1291194A (zh) 2001-04-11
JP2002504554A (ja) 2002-02-12
AU746719B2 (en) 2002-05-02
HRP20000555A2 (en) 2001-08-31
EA200000878A1 (ru) 2001-02-26
TR200002469T2 (tr) 2000-12-21
NZ505695A (en) 2002-03-01
EA002824B1 (ru) 2002-10-31
HUP0100647A2 (hu) 2001-09-28
SK12772000A3 (sk) 2001-03-12
AU2536899A (en) 1999-09-15
EP1070066A1 (en) 2001-01-24
PL341975A1 (en) 2001-05-07

Similar Documents

Publication Publication Date Title
US6743789B2 (en) Substituted imidazo[1,5-a][1,2,4]triazolo[4,3-d][1,4]benzodiazepine derivatives
JP2003513015A (ja) ポリ(adp−リボース)ポリメラーゼの三環系阻害剤
EP0283162B1 (en) Heterocyclic compounds and their preparation and use
JP2000515851A (ja) GABA▲下Aα5▼レセプターサブタイプの逆アゴニストとしての置換のあるトリアゾロピリダジン誘導体
US6313125B1 (en) Therapeutically active 1,2,4-triazolo[4.,3-B] pyridazine derivatives as ligands for GABA receptors
AU2002217007A1 (en) Benzodiazepine derivatives as GABA A receptor modulators
EA002755B1 (ru) Производные триазолопиридазина в качестве лигандов для гамк рецепторов
AU613125B2 (en) Imidazoquinoxaline compounds and their preparation and use
JP2005525392A (ja) 減少された鎮静及び失調効果を有する抗不安薬剤
JP2002501070A (ja) Gaba受容体のリガンドとしてのトリアゾロ−ピリダジン誘導体
US6949549B2 (en) Imidazolophthalazine derivatives as ligands for GABAA receptors
WO2009143445A1 (en) Aza-beta-carbolines and methods of using same
DE69907923T2 (de) Triazolopyridazinderivate zur verbesserung der kognitiven funktionen
BG104705A (bg) Заместен 1,2,4-триазоло/3,4-а/пиридазин
US6448249B1 (en) Substituted 1,2,4-triazolo[3,4-A]phthalazine derivatives as GABAα5 ligands
US6946461B2 (en) Imidazolophthalazine derivatives as ligands for GABAA receptors
JP2001519350A (ja) ナフト−イミダゾ[1,2−a]ピリジン誘導体、その製造及び中枢神経系障害の処置におけるその使用
MXPA00008320A (en) SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PYRIDAZINE
HRP980584A2 (en) SUBSTITUTED 1,2,4-TRIAZOLO/3,4-a/ PHTHALAZINE